“Liquid elbows” due to afatinib administration

Non-small cell lung cancer adenocarcinoma in the past decade has targeted therapies as the cornerstone for therapy. In specific patients with epidermal growth factor receptor mutation have three different therapy approaches with the tyrosine kinase inhibitors: erlotinib, gefitinib and afatinib. Nowa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarogoulidis, Paul, Chinelis, Panos, Athanasiadou, Anastasia, Porpodis, Konstantinos, Kallianos, Anastasios, Rapti, Aggeliki, Trakada, Georgia, Velentza, Lemonia, Huang, Haidong, Tsiouda, Theodora, Hohenforst-Schmidt, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491760/
https://www.ncbi.nlm.nih.gov/pubmed/28702338
http://dx.doi.org/10.1016/j.rmcr.2017.06.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491760/
https://www.ncbi.nlm.nih.gov/pubmed/28702338
http://dx.doi.org/10.1016/j.rmcr.2017.06.013

Ejemplares similares